Distinct roles for ERK1 and ERK2 in pathophysiology of CNS

Frontiers in Biology

Volumn 7, Issue 3, 2012, Pages 267-276

  Yu, Chen Guang ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

cell death; cell proliferation; ERK isoform; neurodegeneration; neuroprotection

Indexed keywords

EID: 84861462189     PISSN: 16747984     EISSN: 16747992     Source Type: Journal    
DOI: 10.1007/s11515-012-1220-4     Document Type: Review

References (82)

1. Adams J P, Roberson E D, English J D, Selcher J C, Sweatt J D (2000) MAPK regulation of gene expression in the central nervous system. Acta Neurobiol Exp (Wars), 60: 377-394.
2. Agrawal A, Dillon S, Denning T L, Pulendran B (2006). ERK1/mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J Immunol, 176: 5788-5796.
3. Alter B J, Zhao C, Karim F, Landreth G E, Gereau RW (2010). Genetic targeting of ERK1 suggests a predominant role for ERK2 in murine pain models. J Neurosci, 30: 11537-11547.
4. Ankeny D P, Guan Z, Popovich P G (2009). B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest, 119: 2990-2999.
5. Bardoni R, Ghirri A, Zonta M, Betelli C, Vitale G, Ruggieri V, Sandrini M, Carmignoto G (2010). Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn. The Journal of physiology, 588: 831-846.
6. Brambilla R, Hurtado A, Persaud T, Esham K, Pearse D D, Oudega M, Bethea J R (2009). Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem, 110: 765-778.
7. Byrnes K R, Stoica B A, Fricke S, Di Giovanni S, Faden A I (2007). Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain, 130: 2977-2992.
8. Cargnello M, Roux P P (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev, 75: 50-83.
9. Carrier N, Kabbaj M (2012). Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone. Biol Psychiatry, Available online 20 January 2012.
10. Chen Z, Gibson T B, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb M H (2001). MAP kinases. Chem Rev, 101: 2449-2476.
11. Cheung EC, Slack R S (2004). Emerging role for ERK as a key regulator of neuronal apoptosis. Sci STKE, 2004: PE45.
12. Chu C T, Levinthal D J, Kulich S M, Chalovich E M, DeFranco D B (2004). Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem, 271: 2060-2066.
13. Colucci-D'Amato L, Perrone-Capano C, di Porzio U (2003). Chronic activation of ERK and neurodegenerative diseases. Bioessays, 25: 1085-1095.
14. D'souza WN, Chang C F, Fischer A M, Li M, Hedrick SM (2008). The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol, 181: 7617-7629.
15. Domercq M, Alberdi E, Sanchez-Gomez M V, Ariz U, Perez-Samartin A, Matute C (2011). Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death. J Biol Chem, 286: 11825-11836.
16. Fleming J C, Norenberg M D, Ramsay D A, Dekaban G A, Marcillo A E, Saenz A D, Pasquale-Styles M, Dietrich W D, Weaver L C (2006). The cellular inflammatory response in human spinal cords after injury. Brain, 129: 3249-3269.
17. Fyffe-Maricich S L, Karlo J C, Landreth G E, Miller R H (2011). The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci, 31: 843-850.
18. Genovese T, Esposito E, Mazzon E, Muia C, Di Paola R, Meli R, Bramanti P, Cuzzocrea S (2008). Evidence for the role of mitogenactivated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther, 325: 100-114.
19. Goplen N, Karim Z, Guo L, Zhuang Y, Huang H, Gorska MM, Gelfand E, Pages G, Pouyssegur J, Alam R (2012). ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J, Available online 18 Jan 2012.
20. Grueter B A, Gosnell H B, Olsen CM, Schramm-Sapyta N L, Nekrasova T, Landreth G E, Winder D G (2006). Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced longterm depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J Neurosci, 26: 3210-3219.
21. Hallett P J, Standaert D G (2004). Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther, 102: 155-174.
22. Hetman M, Gozdz A (2004). Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem, 271: 2050-2055.
23. Hulsebosch C E, Hains B C, Crown E D, Carlton S M (2009). Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res Rev, 60: 202-213.
24. Hynd M R, Scott H L, Dodd P R (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int, 45: 583-595.
25. Imamura O, Pages G, Pouyssegur J, Endo S, Takishima K (2010). ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. Genes Cells, 15: 1072-1088.
26. Imamura O, Satoh Y, Endo S, Takishima K (2008). Analysis of extracellular signal-regulated kinase 2 function in neural stem/progenitor cells via nervous system-specific gene disruption. Stem Cells, 26: 3247-3256.
27. Indrigo M, Papale A, Orellana D, Brambilla R (2010). Lentiviral vectors to study the differential function of ERK1 and ERK2 MAP kinases. Methods Mol Biol, 661: 205-220.
28. Ji R R, Gereau R Wt, Malcangio M, Strichartz G R (2009). MAP kinase and pain. Brain Res Rev, 60: 135-148.
29. Ji RR, Woolf C J (2001). Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis, 8: 1-10.
30. Kaminska B (2005). MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochimica et biophysica acta, 1754: 253-262.
31. Kaminska B, Gozdz A, Zawadzka M, Ellert-Miklaszewska A, Lipko M (2009). MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec (Hoboken), 292: 1902-1913.
32. Kawasaki Y, Zhang L, Cheng J K, Ji R R (2008). Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci, 28: 5189-5194.
33. Keane R W, Davis A R, Dietrich W D (2006). Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma, 23: 335-344.
34. Kolch W (2000). Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J, 351(Pt 2): 289-305.
35. Krens S F, Corredor-Adamez M, He S, Snaar-Jagalska B E, Spaink H P (2008a). ERK1 and ERK2 MAPK are key regulators of distinct gene sets in zebrafish embryogenesis. BMC Genomics, 9: 196.
36. Krens S F, He S, Lamers G E, Meijer A H, Bakkers J, Schmidt T, Spaink H P, Snaar-Jagalska B E (2008b). Distinct functions for ERK1 and ERK2 in cell migration processes during zebrafish gastrulation. Dev Biol, 319: 370-383.
37. Liu L, Zhang R, Liu K, Zhou H, Tang Y, Su J, Yu X, Yang X, Tang M, Dong Q (2009). Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1. J Neurosci Res, 87: 3576-3590.
38. Lloyd AC (2006). Distinct functions for ERKs? J Biol, 5: 13.
39. Lu Z, Xu S (2006). ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Lif, 58: 621-631.
40. Marchi M, D'Antoni A, Formentini I, Parra R, Brambilla R, Ratto G M, Costa M (2008). The N-terminal domain of ERK1 accounts for the functional differences with ERK2. PLoS One, 3: e3873.
41. Matsumoto S, Miyagishi M, Akashi H, Nagai R, Taira K (2005). Analysis of double-stranded RNA-induced apoptosis pathways using interferon-response noninducible small interfering RNA expression vector library. J Biol Chem, 280: 25687-25696.
42. Matute C (2011). Glutamate and ATP signalling in white matter pathology. J Anat, 219: 53-64.
43. Matute C, Alberdi E, Domercq M, Sanchez-Gomez M V, Perez-Samartin A, Rodriguez-Antiguedad A, Perez-Cerda F (2007). Excitotoxic damage to white matter. J Anat, 210: 693-702.
44. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pages G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Ehrengruber MU, Cestari V, Lipp H P, Chapman P F, Pouyssegur J, Brambilla R (2002). Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron, 34: 807-820.
45. Mebratu Y, Tesfaigzi Y (2009). How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle, 8: 1168-1175.
46. Meloche S, Pouyssegur J (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene, 26: 3227-3239.
47. Nakazawa T, Shimura M, Ryu M, Nishida K, Pages G, Pouyssegur J, Endo S (2008). ERK1 plays a critical protective role against Nmethyl-D-aspartate-induced retinal injury. J Neurosci Res, 86: 136-144.
48. Narita M, Ioka M, Suzuki M, Suzuki T (2002). Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neuroscience letters, 324: 97-100.
49. Nekrasova T, Shive C, Gao Y, Kawamura K, Guardia R, Landreth G, Forsthuber T G (2005). ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis. J Immunol, 175: 2374-2380.
50. Otani N, Nawashiro H, Fukui S, Ooigawa H, Ohsumi A, Toyooka T, Shima K (2007). Role of the activated extracellular signal-regulated kinase pathway on histological and behavioral outcome after traumatic brain injury in rats. J Clin Neurosci, 14: 42-48.
51. Pajoohesh-Ganji A, Byrnes KR (2011). Novel neuroinflammatory targets in the chronically injured spinal cord. Neurotherapeutics, 8: 195-205.
52. Park E, Velumian A A, Fehlings M G (2004). The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma, 21: 754-774.
53. Pezet S, Cunningham J, Patel J, Grist J, Gavazzi I, Lever I J, Malcangio M (2002). BDNF modulates sensory neuron synaptic activity by a facilitation of GABA transmission in the dorsal horn. Molecular and cellular neurosciences, 21: 51-62.
54. Pizza V, Agresta A, D'Acunto C W, Festa M, Capasso A (2011). Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord Drug Targets, 10: 621-634.
55. Roux PP, Blenis J (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev, 68: 320-344.
56. Samuels I S, Karlo J C, Faruzzi A N, Pickering K, Herrup K, Sweatt JD, Saitta S C, Landreth G E (2008). Deletion of ERK2 mitogenactivated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J Neurosci, 28: 6983-6995.
57. Sanjo H, Hikida M, Aiba Y, Mori Y, Hatano N, Ogata M, Kurosaki T (2007). Extracellular signal-regulated protein kinase 2 is required for efficient generation of B cells bearing antigen-specific immunoglobulin G. Molecular and Cellular Biology, 27: 1236-1246.
58. Satoh Y, Endo S, Ikeda T, Yamada K, Ito M, Kuroki M, Hiramoto T, Imamura O, Kobayashi Y, Watanabe Y, Itohara S, Takishima K (2007). Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J Neurosci, 27: 10765-10776.
59. Satoh Y, Endo S, Nakata T, Kobayashi Y, Yamada K, Ikeda T, Takeuchi A, Hiramoto T, Watanabe Y, Kazama T (2011a). ERK2 contributes to the control of social behaviors in mice. J Neurosci, 31: 11953-11967.
60. Satoh Y, Kobayashi Y, Takeuchi A, Pages G, Pouyssegur J, Kazama T (2011b). Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice. J Neurosci, 31: 1149-1155.
61. Seger R, Krebs E G (1995). The MAPK signaling cascade. FASEB J, 9: 726-735.
62. Selcher J C, Nekrasova T, Paylor R, Landreth G E, Sweatt J D (2001). Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem, 8: 11-19.
63. Siuciak J A, Altar C A, Wiegand S J, Lindsay R M (1994). Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Research, 633: 326-330.
64. Song X S, Cao J L, Xu Y B, He J H, Zhang L C, Zeng Y M (2005). Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacologica Sinica, 26: 789-798.
65. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri M R, Johnson J W, DeFranco D B (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem, 275: 12200-12206.
66. Stariha R L, Kim S U (2001). Mitogen-activated protein kinase signalling in oligodendrocytes: a comparison of primary cultures and CG-4. Int J Dev Neurosci, 19: 427-437.
67. Subramaniam S, Unsicker K (2006). Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death. Neuroscience, 138: 1055-1065.
68. Subramaniam S, Unsicker K (2010). ERK and cell death: ERK1/2 in neuronal death. FEBS J, 277: 22-29.
69. Suter M R, Wen Y R, Decosterd I, Ji R R (2007). Do glial cells control pain? Neuron Glia biology, 3: 255-268.
70. Tronson N C, Schrick C, Fischer A, Sananbenesi F, Pages G, Pouyssegur J, Radulovic J (2008). Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology, 33: 1570-1583.
71. Tzschentke T M (2002). Glutamatergic mechanisms in different disease states: overview and therapeutical implications - an introduction. Amino Acids, 3: 147-152.
72. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R (2006). ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol, 5: 14.
73. Wang Y, Qin Z H (2010). Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis, 15: 1382-1402.
74. Xu Q, Garraway S M, Weyerbacher A R, Shin S J, Inturrisi C E (2008). Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund's adjuvant-induced pain hypersensitivity. J Neurosci, 28: 14087-14096.
75. Yao Y, Li W, Wu J, Germann U A, Su M S, Kuida K, Boucher D M (2003). Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA, 100: 12759-12764.
76. Yoon S, Seger R (2006). The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors, 24: 21-44.
77. Yu C G, Yezierski R P (2005). Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury. Brain Res Mol Brain Res, 138: 244-255.
78. Yu C G, Yezierski R P, Joshi A, Raza K, Li Y, Geddes J W (2010). Involvement of ERK2 in traumatic spinal cord injury. J Neurochem, 113: 131-142.
79. Zhao P, Waxman S G, Hains B C (2007). Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci, 27: 2357-2368.
80. Zhou X, Li D, Resnick M B, Behar J, Wands J, Cao W (2011). Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells. J Pharmacol Exp Ther, 339: 218-227.
81. Zhuang S, Schnellmann R G (2006). A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther, 319: 991-997.
82. Zhuang Z Y, Gerner P, Woolf C J, Ji R R (2005). ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain, 114: 149-159.